Monoclonal antibody-based therapies for microbial diseases
- 30 December 2009
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 27, G38-G46
- https://doi.org/10.1016/j.vaccine.2009.09.105
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Progress on the development of therapeutics against West Nile virusAntiviral Research, 2009
- Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2009
- Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interfaceProceedings of the National Academy of Sciences of the United States of America, 2009
- Therapeutic antibodies: successes, limitations and hopes for the futureBritish Journal of Pharmacology, 2009
- Antibody Recognition of a Highly Conserved Influenza Virus EpitopeScience, 2009
- Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitorsCurrent Opinion in HIV and AIDS, 2009
- CCR5 monoclonal antibodies for HIV-1 therapyCurrent Opinion in HIV and AIDS, 2009
- Gnotobiotic Piglet Infection Model for Evaluating the Safe Use of Antibiotics againstEscherichia coliO157:H7 InfectionThe Journal of Infectious Diseases, 2009
- Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificityVirology, 2008
- Antibody-Guided Alpha Radiation Effectively Damages Fungal BiofilmsAntimicrobial Agents and Chemotherapy, 2006